肺功能未阻塞人群中COPD的过度诊断:BOLD研究分析
基于BOLD研究2003-2012年20国23个人群样本,在16,177名参与者中,919人(5.7%)报告曾被医生诊断COPD,其中61.9%支气管舒张后肺功能未阻塞,属假阳性COPD;假阳性者中45.7%使用呼吸药物,提示过度诊断可能导致不必要用药。
要点
- 报告COPD诊断者中61.9%肺功能未阻塞,假阳性常见。
- 假阳性COPD在女性、高教育、吸烟及有呼吸道症状者中更常见。
- 假阳性者45.7%使用呼吸药物,可能面临药物不良反应风险。
核心结论
- COPD假阳性诊断常见,可能使肺功能未阻塞者暴露于呼吸药物不良反应风险。
研究设计与样本
- 基于BOLD研究2003-2012年20国23个人群样本的横断面分析,共16,177名参与者。
- 假阳性COPD定义为报告医生诊断COPD但支气管舒张后FEV1/FVC>LLN。
主要发现
- 919名(5.7%)报告既往COPD诊断,其中569名(61.9%)肺功能未阻塞,为假阳性COPD。
- 使用固定比值标准(FEV1/FVC<0.7)时过度诊断率为55.3%。
- 排除报告慢性支气管炎或肺气肿者(n=220)后,37.7%无气流受限。
- 假阳性COPD的站点特异性患病率从低收入至中等收入国家的1.9%到高收入国家的4.9%不等。
- 多因素分析显示过度诊断在女性、高教育、既往和当前吸烟、有喘息咳嗽咳痰及合并哮喘或心脏病诊断者中更常见。
关键数值与推荐
- 假阳性COPD定义为报告医生诊断COPD但支气管舒张后FEV1/FVC>LLN。
- 固定比值标准为FEV1/FVC<0.7。
- 假阳性COPD者中45.7%报告当前使用呼吸药物;排除报告哮喘者后,34.4%肺功能正常者仍使用呼吸药物。
临床怎么用
- 对报告COPD诊断者应复核支气管舒张后肺功能,避免假阳性诊断导致不必要用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are several reports on underdiagnosis of COPD, while little is known about COPD overdiagnosis and overtreatment. We describe the overdiagnosis and the prevalence of spirometrically defined false positive COPD, as well as their relationship with overtreatment across 23 population samples in 20 countries participating in the BOLD Study between 2003 and 2012. METHODS: A false positive diagnosis of COPD was considered when participants reported a doctor's diagnosis of COPD, but postbronchodilator spirometry was unobstructed (FEV1/FVC > LLN). Additional analyses were performed using the fixed ratio criterion (FEV1/FVC < 0.7). RESULTS: Among 16,177 participants, 919 (5.7%) reported a previous medical diagnosis of COPD. Postbronchodilator spirometry was unobstructed in 569 subjects (61.9%): false positive COPD. A similar rate of overdiagnosis was seen when using the fixed ratio criterion (55.3%). In a subgroup analysis excluding participants who reported a diagnosis of "chronic bronchitis" or "emphysema" (n = 220), 37.7% had no airflow limitation. The site-specific prevalence of false positive COPD varied greatly, from 1.9% in low- to middle-income countries to 4.9% in high-income countries. In multivariate analysis, overdiagnosis was more common among women, and was associated with higher education; former and current smoking; the presence of wheeze, cough, and phlegm; and concomitant medical diagnosis of asthma or heart disease. Among the subjects with false positive COPD, 45.7% reported current use of respiratory medication. Excluding patients with reported asthma, 34.4% of those with normal spirometry still used a respiratory medication. CONCLUSIONS: False positive COPD is frequent. This might expose nonobstructed subjects to possible adverse effects of respiratory medication.
引用
- Sator L, Horner A, Studnicka M, et al. Overdiagnosis of COPD in Subjects With Unobstructed Spirometry: A BOLD Analysis. Chest. 2019. PMID: 30711480. doi:10.1016/j.chest.2019.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。